- Easy Tracking In The Watchlist
Volatile ride for Cadrenal Therapeutics, Inc. stock price on Thursday moving between $3.19 and $3.60
(Updated on Jun 18, 2026)
The Cadrenal Therapeutics, Inc. stock price gained 12.90% on the last trading day (Thursday, 18th Jun 2026), rising from $3.10 to $3.50. During the last trading day the stock fluctuated 12.85% from a day low at $3.19 to a day high of $3.60. The price has fallen in 6 of the last 10 days and is down by -18.79% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 27 thousand more shares were traded than the day before. In total, 115 thousand shares were bought and sold for approximately $403.24 thousand.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -21.00% during the next 3 months and, with a 90% probability hold a price between $2.27 and $4.61 at the end of this 3-month period.
CVKD Signals & Forecast
A buy signal was issued from a pivot bottom point on Tuesday, June 16, 2026, and so far it has risen 15.13%. Further rise is indicated until a new top pivot has been found. Cadrenal Therapeutics, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Cadrenal Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.55 and $4.88. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Cadrenal Therapeutics, Inc. stock
Cadrenal Therapeutics, Inc. finds support from accumulated volume at $3.33 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.410 between high and low, or 12.85%. For the last week, the stock has had daily average volatility of 17.44%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (CVKD) For The Upcoming Trading Day Of Monday 22nd
For the upcoming trading day on Monday, 22nd we expect Cadrenal Therapeutics, Inc. to open at $3.43, and during the day (based on 14 day Average True Range), to move between $3.26 and $3.74, which gives a possible trading interval of +/-$0.488 (+/-14.99%) up or down from last closing price. If Cadrenal Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 14.99% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $3.33 (4.86%) than the resistance at $3.70 (5.71%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Cadrenal Therapeutics, Inc. stock A Buy?
Cadrenal Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.
Current score:
-4.057
Sell Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 22, 2026 - $3.43 ( 2.00%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
CVKD Performance
Trading levels for CVKD
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 3.84 | 9.71% |
| R2 | 3.68 | 5.24% |
| R1 | 3.59 | 2.47% |
| Price | 3.50 | |
| S1 | 3.27 | -6.47% |
| S2 | 3.18 | -9.24% |
| S3 | 3.02 | -13.71% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 4.35 | 24.29% |
| R2 | 4.21 | 20.29% |
| R1 | 3.70 | 5.71% |
| Price | 3.50 | |
| S1 | 3.33 | -4.86% |
| S2 | 3.10 | -11.43% |
| S3 | 3.04 | -13.14% |
FAQ
Click here for our free guide on how to buy Cadrenal Therapeutics, Inc. Stock.
Buy CVKD